Panacea Global Inc (OTCQB:PANG)

Data as of Sep 16
 +0.05 / +16.67%
Today’s Change
Today|||52-Week Range
Real Estate Development

Company Description

Panacea Global, Inc. is a biotechnology company focused on the discovery, development and commercialization of diagnostic products for the management of cancer. The company provides blood, serum and tissue tests to diagnose and monitor cancer through a licensing agreement with Panacea Pharmaceuticals. Its current product line allows for accurate detection of the most common forms of cancer, which includes diagnostic tests for lung, breast, prostate and colon cancers. The company was founded in 1995 and is headquartered in Richmond Hill, Canada.

Contact Information

Panacea Global, Inc.
330 Highway 7 East
Richmond Hill Ontario L4B 3P8
P:(416) 450-6414
Investor Relations:



Individual stakeholders14.80%
Mutual fund holders--
Other institutional--

Top Executives

Mahmood MoshiriPresident, CEO, CFO & Director
Binnay SethiSecretary, Director & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.